U.S. markets closed

Sintx Technologies, Inc. (SINT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4198-0.0181 (-4.13%)
At close: 04:00PM EDT
0.4140 -0.01 (-1.38%)
After hours: 06:10PM EDT

Sintx Technologies, Inc.

1885 West 2100 South
Salt Lake City, UT 84119
United States
801 839 3500

IndustryMedical Devices
Full Time Employees36

Key Executives

NameTitlePayExercisedYear Born
Dr. B. Sonny Bal J.D., M.D., MBA, Ph.D.Chairman, Pres, CEO & Principal Financial Officer444.8kN/A1962
Mr. David Francis O'BrienChief Operating Officer334.28kN/A1965
Ms. Gina MossDirector of OperationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Sintx Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.